HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

P&G Beauty Businesses Could Be Going Coty's Way, Insiders Say

This article was originally published in The Rose Sheet

Executive Summary

Coty could soon be the new owner of P&G's Wella and Clairol hair-care businesses, CoverGirl and Max Factor makeup lines and prestige fragrance licenses, significantly growing Coty's global beauty presence, under a deal rumored to be in the works. Coty's stock jumped nearly 15% following reports that it has won an auction to purchase the brands as part of P&G's streamlining initiative.

You may also be interested in...



Inside The Coty/P&G Beauty Mega Deal

Coty faced off against 44 other interested parties last year to eventually win P&G's beauty business with its $12.5bn merger bid, ushering it to the top tier of the global beauty industry. An April 22 SEC filing offers inside details on Coty and P&G's businesses and how the deal came together.

Coty's Size To Double Following $12.5 Billion P&G Deal

Procter & Gamble will separate 43 of its beauty brands into a new company to merge with Coty in a deal valued at $12.5 billion. The new company will become the third-largest global cosmetics company, behind L'Oreal and Estee Lauder, Coty says.

In Brief: Women's Health Orgs Back Feinstein Bill; Federal Microbeads Ban Gains Support

The Personal Care Products Safety Act has the support of 13 national health organizations, which sent a June 25 letter to the bill's sponsor and the Senate Health Committee welcoming federal oversight reform in the sector. More news in brief.

Related Content

Related Companies

Latest Headlines
See All
UsernamePublicRestriction

Register

RS019540

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel